undamentalytics Newsletter
Sign in

Eyepoint, Inc. balance sheet

At the end of fiscal 2025, Eyepoint, Inc. had total assets of $364m, total liabilities of $57.9m and shareholders' equity of $306m. It held $102m in cash against $0 of debt: net cash of $102m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010Jun 20102011Jun 20112012Jun 20122013Jun 20132014Jun 20142015Jun 20152016Jun 20162017Jun 20172018Jun 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash and equivalents—————————224517996281100102110
Receivables—1111100011918161110
Inventory———————0025434222
Total current assets—25161219303018404263238173345383329189
Total assets—47211623323219727392263180355418364228
Accounts payable—0010111345767121017
Deferred revenue (current)—32100000011139180—
Total current liabilities—5332355221215243563493742
Short-term debt———————————0100———
Long-term debt———————01747383729————
Total debt0000000017473837400000
Total liabilities—107989115606573798489825862
Shareholders' equity3337148152321131281918496266337306166
Net debt (negative = net cash)—————————25−7−142−55−281−100−102−110
Shares outstanding—————————11m—34m34m—68m83m85m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: EYPT vs TXMDCPHI vs EYPTEYPT vs NTRB

More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies

Figures from Eyepoint, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Eyepoint, Inc.